Activity of human monocytes in IgE antibody-dependent surveillance and killing of ovarian tumor cells
✍ Scribed by Sophia N. Karagiannis; Qin Wang; Nick East; Frances Burke; Stephane Riffard; Marguerite G. Bracher; Richard G. Thompson; Stephen R. Durham; Lawrence B. Schwartz; Frances R. Balkwill; Hannah J. Gould
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 412 KB
- Volume
- 33
- Category
- Article
- ISSN
- 0014-2980
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
We have previously shown that a chimeric IgE antibody against the folic acid receptor (MOv18 IgE) inhibits tumor growth in a SCID mouse model of ovarian carcinoma. MOv18 IgE gave greater protection than the corresponding chimeric MOv18 IgG1. We have now confirmed these effects in a nude‐mouse model of ovarian carcinoma and have demonstrated for the first time that human monocytes are active in IgE antibody‐dependent cell‐mediated cytotoxicity. Injection of tumor‐bearing mice with PBMC and MOv18 IgE led to infiltration of monocytes into the tumors and prolonged survival of the mice.Incubation of PBMC or purified monocytes and MOv18 IgE with ovarian tumor cells in vitro resulted in tumor cell killing proportional to the expression of unoccupied FcϵRI on monocytes.We observed phagocytosis of tumor cells by the monocytes in vitro. Our results suggest that tumor‐specific IgE antibodies may be exploited for immunotherapy of cancer.
📜 SIMILAR VOLUMES
Cytokines are directly cytotoxic to tumor cells in vitro and in vivo, and interleukinla (ILla) potentiates the cytotoxicity of a number of clinically active drugs in several human tumor cells, including carcinomas of the breast and ovary. In this study, we found that ILla potentiated the cytotoxicit
## Abstract We have previously described the development and testing of a monoclonal anti‐human CD54 antibody (UV3) in SCID mice xenografted with human multiple myeloma, lymphoma, and melanoma cell lines. In all 3 cases, UV3 was highly effective at slowing the growth of tumors and/or prolonging sur
## Abstract The net balance between urokinase‐type plasminogen activator (uPA) and plasminogen activator inhibitor type‐1 (PAI‐1) has been implicated in tumor cell invasion and metastasis. To elucidate the mechanism of the transforming growth factor‐β1 (TGF‐β1)‐dependent up‐regulation of PAI‐1 expr